Biocon Biologics receives positive CHMP opinions for denosumab biosimilars Vevzuo and Denosumab BBL EP News Bureau Apr 28, 2025 European Medicines Agency’s CHMP recommends approval of Biocon Biologics' denosumab biosimilars for bone health indications
